Dialipid s.r.o.

At Dialipid s.r.o. in Presov, clinical research is focused on nutritional and metabolic diseases, with a strong emphasis on type 2 diabetes and overweight. The trials are designed to assess whether newer treatment approaches can improve blood sugar control and support better metabolic health in everyday care.

• Studies in type 2 diabetes and overweight
• Evaluation of therapies aimed at improving HbA1c and glycaemic control
• Research comparing treatment strategies to see which better supports diabetes management

Overall, the site is contributing to research on how antidiabetic therapies may be used more effectively, including approaches that combine glucose-lowering treatment with insulin adjustment or other metabolic support.

This research area centers on type 2 diabetes care, especially for participants whose blood sugar remains difficult to control. The studies are evaluating whether newer therapies can provide better outcomes than established treatment options, with a focus on improving glucose management and overall treatment effectiveness.

• Comparison of treatments for inadequate glycaemic control
• Assessment of therapies that may improve HbA1c more effectively
• Clinical interest in better long-term management of diabetes

These trials help clarify how emerging diabetes therapies may fit into routine practice for people living with type 2 diabetes, including those already receiving metformin or other standard background treatment.